💊 यो जानकारी मात्र हो, प्रिस्क्रिप्सन होइन। कुनै पनि औषधि लिनुअघि डाक्टर वा फार्मासिस्टसँग सल्लाह लिनुहोस्। ओभरडोज वा विषाक्तता भए १०२ मा फोन गर्नुहोस्।
Hematologic The most common side effect is bone marrow suppression leading to leukopenia, thrombocytopenia, and anemia. White blood cell count and platelet count nadirs usually occur 2 to 3 weeks after treatment, with recovery in 4 to 5 weeks after treatment. Irreversible bone marrow failure has been reported. Pregnancy (label summary): Teratogenic Effects Pregnancy Category D: See WARNINGS section. Breastfeeding (label summary): Nursing Mothers It is not known whether this drug is excreted in human milk. IV melphalan should not be given to nursing mothers. General information only, not medical advice and not a prescription. No doses are given. Always consult a doctor or pharmacist before starting, stopping or changing any medicine, especially in pregnancy, breastfeeding, children, older age or with other medicines.
स्रोत: FDA SPL label (openFDA/DailyMed); RxNorm (NLM) · Reference · Reference · Reference
US FDA DailyMed; NLM RxNorm